The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.
Int J Infect Dis
; 111: 196-203, 2021 Oct.
Article
in English
| MEDLINE | ID: covidwho-2113602
ABSTRACT
OBJECTIVES:
Streptococcus pneumoniae is the leading bacterial pathogen causing respiratory infections. Since the COVID-19 pandemic emerged, less invasive pneumococcal disease (IPD) was identified by surveillance systems worldwide. Measures to prevent transmission of SARS-CoV-2 also reduce transmission of pneumococci, but this would gradually lead to lower disease rates.DESIGN:
Here, we explore additional factors contributing to the instant drop in pneumococcal disease cases captured in surveillance.RESULTS:
Our observations on referral practices and other impediments to diagnostic testing indicate that residual IPD has likely occurred but remained undetected by conventional hospital-based surveillance.CONCLUSIONS:
Depending on the setting, we discuss alternative monitoring strategies that could improve understanding of pneumococcal disease dynamics.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumococcal Infections
/
COVID-19
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Adult
/
Humans
/
Infant
Country/Region as subject:
Europa
Language:
English
Journal:
Int J Infect Dis
Journal subject:
Communicable Diseases
Year:
2021
Document Type:
Article
Affiliation country:
J.ijid.2021.08.060
Similar
MEDLINE
...
LILACS
LIS